BELLICUM PHARMACEUTICALS, INC reports

Company location: Houston, TX
Fiscal year end: 31 December

BELLICUM PHARMACEUTICALS, INC has filed 611 SEC EDGAR filings since 23 Mar 2006

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 101-125 of 606 matching filings.

Per page

25

Current page

5

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Jan 2022
Reporting date: 04 Jan 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 13 Dec 2021
Reporting date: 10 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 09 Dec 2021
Reporting date: 09 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 06 Dec 2021
Reporting date: 04 Dec 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 02 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

FORM 3

Filing date: 02 Dec 2021
Reporting date: 01 Dec 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 04 Nov 2021
Reporting date: 02 Nov 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36783

10-Q

Filing date: 04 Nov 2021
Reporting date: 30 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 13 Sep 2021
Reporting date: 13 Sep 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4/A

FORM 4/A

Filing date: 18 Aug 2021
Reporting date: 16 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 16 Aug 2021
Reporting date: 16 Aug 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-258778

S-8

Filing date: 13 Aug 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36783

8-K

Filing date: 12 Aug 2021
Reporting date: 12 Aug 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

10-Q File 001-36783

10-Q

Filing date: 12 Aug 2021
Reporting date: 30 Jun 2021
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 07 Jul 2021
Reporting date: 15 Jun 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .